DNMT3B Alleviates Liver Steatosis Induced by Chronic Low-grade LPS via Inhibiting CIDEA Expression
Qiang Li(Army Medical University), Guoquan Liu(Bengbu Medical College), Yaju Wang(Bengbu Medical College), Yu Gao(Beijing University of Chinese Medicine), Xinyu Li(Shanghai Jiao Tong University), Wenjing Wang(Bengbu Medical College), Kangyun Shi(Bengbu Medical College), Yinyin Xia(Bengbu Medical College), Feifan Duan(Bengbu Medical College), Shuya Chen(South China Agricultural University)
Cited by 9
Related Papers
Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota
|Cell Reports|2021|120
Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets
|Heliyon|2024|68
MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease
|World Journal of Gastroenterology|2014|59
Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis
|Bioorganic Chemistry|2021|54
Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine
|International Journal of Biological Macromolecules|2023|47